USPTO serial 79312359
EASYMERS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2022
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EASYMERS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Wright
Mark Wright McLane Middleton, Professional Associati900 Elm StreetManchester, NH 03101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use, namely, reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes, namely, Diagnostic reagents and preparations, except for medical or veterinary use, Chemicals for use in industry and science, Chemical preparations for general industrial manufacturing; diagnostic reagents for scientific diagnostic not for medical and veterinary purposes; research reagents for scientific and diagnostic research purposes; diagnostic test materials for scientific and diagnostic purposes not for medical or veterinary purposes, namely, Diagnostic preparations, other than for medical or veterinary purposes, Diagnostic reagents for scientific or research use, Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; chemical reagents, other than for medical or veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes not for medical or veterinary purposes comprised of biochemical reagents used for non-medical purposes; biochemical analysis kits for research and diagnostic purposes not for medical and veterinary purposes comprised of biochemicals for in vitro and in vivo scientific use; biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, including cancer therapy, cancer immunotherapy, analysis or treatment of cancer, infectious diseases and/or autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring and T cell monitoring | ACTIVE | — |
| 005 | Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for development and analysis of vaccines, immunotherapy and cellular therapy, namely, cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for pharmaceutical or medical purposes for use in cancer therapy or other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring, all for medical or veterinary purposes | ACTIVE | — |
| 042 | Scientific and technological analyses of T cells and their responses, namely, research services and design of T cells and their responses; industrial analysis of T cells and their responses, including for development of medicines and vaccines; basic scientific and clinical research on T cells and their responses, including for the development of medicines and vaccines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by immunAware ApS
- Other trademarks owned by immunAware ApS
- Other trademarks owned by immunAware ApS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named EASYMERS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 18, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 18, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 5, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 13, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 11, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 10, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |